Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Hearing aid sits at the center of this dementia and brain health question.
A groundbreaking 3-year clinical trial found that hearing aid use reduced cognitive decline by 48% in older adults at higher risk for dementia—a substantial effect that marks a meaningful shift in dementia prevention research. The ACHIEVE trial, which followed nearly 1,000 adults aged 70 to 84, demonstrated that for people with hearing loss who were already showing signs of cognitive vulnerability, early intervention with hearing aids could slow mental decline significantly more than education or other standard care approaches. This article explores what the trial actually showed, why it matters for older adults and their families, which groups benefited most, and what the broader research landscape reveals about the hearing-dementia connection.
Table of Contents
- What Did the ACHIEVE Trial Actually Discover About Hearing Aids and Cognitive Decline?
- Who Benefits Most from Hearing Aids and Why Does Risk Status Matter?
- How Does Hearing Loss Actually Connect to Cognitive Decline and Dementia Risk?
- What Does It Take to Actually See Cognitive Benefits from Hearing Aids?
- Important Limitations and What the Research Doesn’t Tell Us
- What Do Other Research Findings Show About Hearing and Cognition?
- The Evolving Landscape of Dementia Prevention and Where Hearing Fit In
- Conclusion
What Did the ACHIEVE Trial Actually Discover About Hearing Aids and Cognitive Decline?
The ACHIEVE study was a rigorous randomized controlled trial designed specifically to test whether addressing hearing loss could protect against cognitive decline in aging. researchers enrolled older adults with untreated hearing loss and randomly assigned them to receive either hearing aids along with instruction and support, or general health education. Over three years, they measured cognitive changes in both groups using validated neuropsychological tests. The headline result that caught researchers’ attention: in participants who started the study at higher baseline risk for cognitive decline—typically those with lower cognitive scores at the beginning or advanced age—hearing intervention reduced the rate of cognitive decline by 48%. In a practical sense, this means that people in that high-risk subgroup saw their mental decline slow substantially compared to the control group, suggesting that hearing aid use directly influenced cognitive preservation.
However, a critical nuance emerged when researchers looked at the study population overall: the entire group of 977 participants did not show a statistically significant protection against cognitive decline. This might sound contradictory, but it reflects an important reality in dementia research—benefits often cluster in specific subgroups rather than affecting everyone equally. The data revealed that participants already showing more advanced age or measurable cognitive challenges at baseline experienced the strongest benefits, while younger or cognitively intact participants showed less dramatic effects. This pattern suggests that the window of opportunity for hearing intervention may be most critical for people already on a concerning trajectory, rather than as a universal preventive for all older adults. The research was published in major venues including The Lancet and specialized dementia journals, lending it substantial credibility. What made ACHIEVE especially valuable was its three-year duration—long enough to see real changes in cognition, not just short-term markers or theoretical benefits.
Who Benefits Most from Hearing Aids and Why Does Risk Status Matter?
The subgroup analysis revealing a 48% reduction in cognitive decline was specific: people aged 70 and older with untreated hearing loss who were at higher baseline dementia risk. “Baseline dementia risk” in this context includes factors like already-declining cognitive test scores, family history of dementia, or age beyond 75. These are the people for whom every year of cognitive preservation potentially makes a real difference in maintaining independence and quality of life. For them, the addition of hearing aids—combined with instruction on how to use them and encouragement to keep wearing them—appeared to create a measurable cognitive advantage over three years. The reason this risk stratification matters is practical. If hearing aids worked equally for everyone regardless of risk, they could be recommended as universal prevention.
Instead, the evidence suggests a more targeted picture: people already showing cognitive vulnerability or advanced age seem to get the strongest benefit. Someone in their mid-60s with perfect hearing and normal cognition shouldn’t expect the same protective effect as an 80-year-old with hearing loss and early cognitive changes. This doesn’t mean younger people with hearing loss shouldn’t get hearing aids—improved hearing quality of life and connection remain important—but it clarifies that the dementia-prevention angle may be most powerful for older, higher-risk populations. It’s similar to how taking an aspirin for heart disease makes sense if you’re at high cardiovascular risk, but not necessarily for someone with zero risk factors. One limitation here: the ACHIEVE trial enrolled people with existing untreated hearing loss, not people who had worn hearing aids for years already. So we don’t yet have data showing whether starting hearing aids earlier in life might prevent cognitive decline from occurring in the first place, or whether the benefits continue beyond three years.
How Does Hearing Loss Actually Connect to Cognitive Decline and Dementia Risk?
The biological connection between hearing loss and cognitive decline isn’t merely coincidental; researchers have identified several plausible mechanisms. Untreated hearing loss forces the brain to work harder to extract meaning from sound—a phenomenon called “effortful listening.” When you’re constantly struggling to understand speech, you’re diverting cognitive resources away from other mental functions and toward auditory processing. Imagine trying to focus on a book while someone is speaking in a language you barely understand in the background—your attention narrows, your mental energy depletes, and your capacity for other thinking tasks shrinks. Over years, this sustained cognitive burden may accelerate age-related declines in memory and processing speed. Additionally, hearing loss often leads to social withdrawal. When conversations become difficult and embarrassing, older adults tend to isolate themselves—skipping family gatherings, avoiding phone calls, withdrawing from activities.
Social isolation itself is a known risk factor for dementia nearly as strong as smoking or obesity. Hearing aids restore the ability to participate in conversation and maintain social connections, which has independent protective effects on the brain. A person wearing hearing aids can rejoin their book club, answer their grandchildren’s questions, and engage in the mental stimulation that keeps cognitive gears turning. The 2024 Lancet Commission on dementia explicitly noted that evidence for treating hearing loss to reduce dementia risk has become “stronger than when our previous Commission report was published,” reflecting growing recognition of this pathway. A secondary analysis from 2025 further illuminated this: the cognitive benefits of hearing intervention varied significantly by baseline risk. This supports the idea that people who are already cognitively vulnerable gain more when the neurological burden of untreated hearing loss is lifted—their brains may have less reserve to spare.
What Does It Take to Actually See Cognitive Benefits from Hearing Aids?
Based on ACHIEVE and related research, getting the cognitive benefit isn’t simply about obtaining hearing aids and letting them sit in a drawer. In the trial, the hearing intervention group received not just devices but also instruction on use, expectations about adjustment, counseling on benefits, and ongoing encouragement. Real-world hearing aid success requires commitment: wearing them consistently (ideally all day), getting proper fitting and calibration, returning for adjustments, and sticking with them through an adjustment period. Many older adults abandon hearing aids within the first year if expectations aren’t managed or if they’re uncomfortable. The cognitive benefits observed in ACHIEVE likely depended on consistent, daily use over the full three years. The comparison with the control group (which received health education) also hints at what’s required. The control group wasn’t denied any care; they received valuable information about healthy aging.
Yet this education alone didn’t protect cognition as effectively as the hearing intervention for high-risk participants. This suggests that the specific act of restoring auditory input and social engagement carries particular weight. It’s not enough to tell someone “stay mentally active”—actually removing the barrier that hearing loss creates (so they can be mentally active) makes a measurable difference. Cost and access also matter in the real world. Modern hearing aids range from hundreds to thousands of dollars, and many people remain untreated because of cost, stigma, or lack of awareness. Some insurance plans and hearing aid voucher programs are expanding, but coverage remains uneven. For people who can access and afford devices, the three-year cognitive protection observed in ACHIEVE represents genuine value. However, if cost or access barriers prevent someone from trying hearing aids, the research doesn’t yet tell us whether less expensive or over-the-counter alternatives (which have become more available) produce the same cognitive benefits—that gap remains an important unanswered question.
Important Limitations and What the Research Doesn’t Tell Us
While the ACHIEVE trial’s 48% reduction in cognitive decline for high-risk participants is impressive, several important caveats apply. First, the study measured overall cognitive decline, not specific dementia diagnosis. Cognitive decline and dementia are related but distinct; someone could show slower cognitive decline without reaching a dementia diagnosis, or vice versa. We don’t yet know whether the hearing intervention translates to fewer dementia diagnoses or maintained independence in daily living. That distinction matters for people trying to decide whether the effort and expense of hearing aids will genuinely prevent dementia or merely slow a decline that will continue anyway. Second, the ACHIEVE study enrolled people with untreated hearing loss—we have no equivalent three-year trial of people who started hearing aids much earlier in life (say, at age 50 or 55) to see whether early intervention provides even greater protection.
Similarly, we don’t know whether benefits continue beyond three years. If the effect plateaus, continues to accumulate, or reverses once hearing aids are stopped, that would change the calculus for long-term use. Third, the control group received general health education, not a placebo or standard care. It’s possible that combining hearing aids with additional support, encouragement, and cognitive monitoring provided benefits beyond just the hearing aid itself. There’s also a risk of overstating individual agency: some people may try hearing aids, follow all recommendations, and still experience cognitive decline simply because their genetic risk, disease burden, or other factors override the protective effect of treating hearing loss. Hearing aids are a meaningful intervention for many, but they’re not a guarantee against dementia. Additionally, some older adults with cognitive decline (particularly those in later dementia stages) may have difficulty adjusting to hearing aids or tolerating them, limiting their usefulness in the most vulnerable populations.
What Do Other Research Findings Show About Hearing and Cognition?
The ACHIEVE trial wasn’t the only recent research validating the hearing-cognition link. An Australian longitudinal study tracking 1,846 participants over 12 years found that hearing aid use was associated with a 19% reduction in cognitive decline rates among those with hearing loss. While this is a smaller effect size than ACHIEVE’s 48% reduction, it’s from a much longer observational study (rather than a controlled trial) and provides complementary evidence across a different population. Other studies have found that untreated hearing loss is associated with faster cognitive aging, accelerated brain atrophy in regions linked to hearing and memory, and increased dementia risk—associations that improve when hearing loss is treated.
Neuroimaging research offers mechanistic support: older adults with untreated hearing loss show altered patterns of brain activity during listening tasks, suggesting the brain is compensating or struggling. When hearing aids are introduced, some of these patterns normalize or improve. While imaging changes don’t directly prove cognitive benefit, they point to the same neurobiological story: hearing loss strains the brain, and restoration allows it to function more normally. The 2024 Lancet Commission on dementia, which reviews evidence across the full aging-dementia landscape, elevated the status of hearing loss treatment as a dementia risk modifier. Their assessment—that evidence for treating hearing loss to reduce dementia risk has become “stronger than when our previous Commission report was published”—reflects years of accumulating research across multiple study types and populations.
The Evolving Landscape of Dementia Prevention and Where Hearing Fit In
Historically, dementia prevention felt like an impossible goal. Many people assumed cognitive decline was an inevitable part of aging. But the past decade has shifted that narrative. Research on modifiable risk factors—education, physical activity, cognitive engagement, cardiovascular health, hearing, vision, sleep—has shown that dementia isn’t entirely written in genetics; lifestyle and medical factors do matter.
Hearing loss treatment now occupies a recognized place in that preventive toolkit, especially for older adults at higher baseline risk. Looking forward, several questions remain open. Will early intervention in hearing loss (beginning in one’s 50s or 60s) prove even more protective than waiting until 70 or 80? Will newer over-the-counter hearing aids, which are more accessible and affordable, provide similar cognitive benefits if used consistently? And can hearing treatment be combined with other interventions—say, cognitive training, physical exercise, and cardiovascular management—to create even stronger protection? The ACHIEVE trial provides a foundation, but the full story is still being written. For now, the evidence suggests that if you’re an older adult with hearing loss and you’re concerned about cognitive aging, treating that hearing loss with professional-grade hearing aids is a reasonable, evidence-backed step that may slow decline, maintain social connection, and preserve the cognitive function you have. That’s a concrete takeaway from three years of rigorous research.
Conclusion
The ACHIEVE trial’s discovery that hearing aid use reduced cognitive decline by 48% in older adults at higher risk for dementia offers one of the clearest pieces of evidence yet that a modifiable health factor—in this case, untreated hearing loss—meaningfully influences cognitive aging. For people aged 70 and older with hearing loss and baseline cognitive vulnerability, professional hearing aid fitting, proper use, and consistent wear appear to slow the rate of mental decline substantially over three years. This isn’t a cure for dementia, nor does it apply equally to all older adults, but for a significant subgroup it represents a meaningful intervention.
If you or a loved one has untreated hearing loss and concerns about cognitive aging, the evidence now supports a conversation with an audiologist about evaluation and fitting. Hearing aids offer both immediate quality-of-life benefits—reconnecting with loved ones, staying engaged in social and cognitive activities—and potential longer-term cognitive protection. While more research is needed on early intervention, long-term sustainability of benefits, and optimization strategies, the ACHIEVE trial marks a turning point in recognizing hearing health as part of dementia prevention rather than a separate issue. The window of opportunity appears to be during the earlier stages of older adulthood, when hearing loss is treatable and cognitive reserve is still substantial.
You Might Also Like
- Why People Who Speak Two Languages Develop Dementia Symptoms 4 Years Later Than Monolinguals
- Why Depression in Midlife May Be an Early Sign of Dementia and Not Just a Mood Disorder
- The Relationship Between Retirement Age and Dementia Risk That Researchers Just Quantified
For more, see CDC — Alzheimer’s and Dementia.
